T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

Clinical trial NCT05756556 · SUSPENDED

Trial details

NCT number: NCT05756556
Sponsor: ImmVira Pharma Co. Ltd
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Malignant Melanoma

Start date: 2024-06-30
Primary completion: 2026-12-31
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.